FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308954619> ?p ?o ?g. }

• W4308954619 endingPage "57" @default.
• W4308954619 startingPage "43" @default.
• W4308954619 abstract "Targeted pharmacotherapy has been increasingly applied in cancer treatment due to its breakthroughs. However, the unmet needs of cancer patients are still significant, highlighting the urgency to investigate patient preferences. It is unclear how patients deliberate their choices between different aspects of targeted therapy, including cost, efficacy, and adverse events. Since discrete choice experiments (DCEs) have been widely applied to patient preference elicitation, we reviewed DCEs on targeted therapy for different cancers. We also synthesized evidence on the factors influencing patients’ choices and their willingness-to-pay (WTP) for survival when treated by targeted therapy. We searched databases, including PubMed, EMBASE and MEDLINE, up to August 16, 2022, supplemented by a reference screening. The attributes from the selected studies were categorized into three groups: outcomes, costs, and process. We also calculated the relative importance of attributes and WTP for survival whenever possible. The purpose, respondents, explanation, findings, significance (PREFS) checklist was used to evaluate the quality of the included DCE studies. The review identified 34 eligible studies from 13 countries covering 14 cancers, such as breast, ovarian, kidney, prostate, and skin cancers. It also reveals a rising trend of DCEs on this topic, as most studies were published after 2018. We found that patients placed higher weights on the outcome (e.g., overall survival) and cost attributes than on process attributes. On average, patients were willing to pay $561 (95% confidence interval [CI]: $415–$758) and $716 (95% CI $524–$958) out-of-pocket for a 1-month increase in progression-free survival and overall survival, respectively. PREFS scores of the 34 studies ranged from 2 to 4, with a mean of 3.38 (SD: 0.65), suggesting a reasonable quality based on the checklist. However, most studies (n = 32, 94%) did not assess the impact of non-responses on the results. This is the first systematic review focusing on patient preferences for targeted cancer therapy. We showcased novel approaches for evidence synthesis of DCE results, especially the attribute relative importance and WTP. The results may inform stakeholders about patient preferences toward targeted therapy and their WTP estimates. More studies with improved study design and quality are warranted to generate more robust evidence to assist decision making." @default.
• W4308954619 created "2022-11-20" @default.
• W4308954619 creator A5019795468 @default.
• W4308954619 creator A5024956914 @default.
• W4308954619 creator A5031512702 @default.
• W4308954619 creator A5041835654 @default.
• W4308954619 creator A5043629216 @default.
• W4308954619 creator A5077153113 @default.
• W4308954619 date "2022-11-14" @default.
• W4308954619 modified "2023-10-17" @default.
• W4308954619 title "Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments" @default.
• W4308954619 cites W1793299609 @default.
• W4308954619 cites W1829247971 @default.
• W4308954619 cites W1933249960 @default.
• W4308954619 cites W1939947931 @default.
• W4308954619 cites W1996396095 @default.
• W4308954619 cites W2006161219 @default.
• W4308954619 cites W2010838798 @default.
• W4308954619 cites W2024491306 @default.
• W4308954619 cites W2029480581 @default.
• W4308954619 cites W2039607804 @default.
• W4308954619 cites W2044053247 @default.
• W4308954619 cites W2048732444 @default.
• W4308954619 cites W2060427373 @default.
• W4308954619 cites W2081573465 @default.
• W4308954619 cites W2091372427 @default.
• W4308954619 cites W2117595153 @default.
• W4308954619 cites W2118709942 @default.
• W4308954619 cites W2121619367 @default.
• W4308954619 cites W2122707212 @default.
• W4308954619 cites W2133413668 @default.
• W4308954619 cites W2159936838 @default.
• W4308954619 cites W2186464704 @default.
• W4308954619 cites W2339311613 @default.
• W4308954619 cites W2367707061 @default.
• W4308954619 cites W2419312609 @default.
• W4308954619 cites W2538851935 @default.
• W4308954619 cites W2547875670 @default.
• W4308954619 cites W2554495646 @default.
• W4308954619 cites W2556805297 @default.
• W4308954619 cites W2572175173 @default.
• W4308954619 cites W2601280897 @default.
• W4308954619 cites W2602989120 @default.
• W4308954619 cites W2604325301 @default.
• W4308954619 cites W2608581628 @default.
• W4308954619 cites W2762484031 @default.
• W4308954619 cites W2767285760 @default.
• W4308954619 cites W2787553551 @default.
• W4308954619 cites W2806971327 @default.
• W4308954619 cites W2807554669 @default.
• W4308954619 cites W2885338180 @default.
• W4308954619 cites W2895773179 @default.
• W4308954619 cites W2899892038 @default.
• W4308954619 cites W2910205558 @default.
• W4308954619 cites W2912558105 @default.
• W4308954619 cites W2913571920 @default.
• W4308954619 cites W2931692870 @default.
• W4308954619 cites W2964088882 @default.
• W4308954619 cites W2980936987 @default.
• W4308954619 cites W2982522628 @default.
• W4308954619 cites W2997722341 @default.
• W4308954619 cites W2998983319 @default.
• W4308954619 cites W3001632091 @default.
• W4308954619 cites W3004565989 @default.
• W4308954619 cites W3005867736 @default.
• W4308954619 cites W3013446577 @default.
• W4308954619 cites W3015688173 @default.
• W4308954619 cites W3015888395 @default.
• W4308954619 cites W3022736034 @default.
• W4308954619 cites W3035488688 @default.
• W4308954619 cites W3039490980 @default.
• W4308954619 cites W3044477544 @default.
• W4308954619 cites W3045502495 @default.
• W4308954619 cites W3047411303 @default.
• W4308954619 cites W3048924742 @default.
• W4308954619 cites W3080356746 @default.
• W4308954619 cites W3091303819 @default.
• W4308954619 cites W3096961609 @default.
• W4308954619 cites W3111181728 @default.
• W4308954619 cites W3118615836 @default.
• W4308954619 cites W3119695293 @default.
• W4308954619 cites W3122508700 @default.
• W4308954619 cites W3125446430 @default.
• W4308954619 cites W3128646645 @default.
• W4308954619 cites W3137654448 @default.
• W4308954619 cites W3140706905 @default.
• W4308954619 cites W3157929507 @default.
• W4308954619 cites W3177746299 @default.
• W4308954619 cites W3209453749 @default.
• W4308954619 cites W4200331559 @default.
• W4308954619 cites W4214685613 @default.
• W4308954619 cites W4226365895 @default.
• W4308954619 cites W4292265583 @default.
• W4308954619 doi "https://doi.org/10.1007/s40273-022-01198-8" @default.
• W4308954619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36372823" @default.
• W4308954619 hasPublicationYear "2022" @default.
• W4308954619 type Work @default.
• W4308954619 citedByCount "5" @default.

• next